Skip to main content

Articles

298 result(s) within Volume 6 of BMC Cancer

Page 1 of 6

  1. Overexpression of Fra-1 in fibroblasts causes anchorage-independent cell growth and oncogenic transformation. A high level of Fra-1 expression is found in various tumors and tumorigenic cell lines, suggesting ...

    Authors: Yuhua Song, Santai Song, Dong Zhang, Yan Zhang, Liyong Chen, Lu Qian, Ming Shi, Huibin Zhao, Zefei Jiang and Ning Guo
    Citation: BMC Cancer 2006 6:298
  2. Breast cancer is the second leading cause of cancer deaths in women in the United States. Although the causes of this disease are incompletely understood, oxidative DNA damage is presumed to play a critical ro...

    Authors: Simon G Nyaga, Althaf Lohani, Pawel Jaruga, Andrzej R Trzeciak, Miral Dizdaroglu and Michele K Evans
    Citation: BMC Cancer 2006 6:297
  3. The development of esophageal squamous cell carcinoma (ESCC) progresses a multistage process, collectively known as precursor lesions, also called dysplasia (DYS) and carcinoma in situ (CIS), subsequent invasive ...

    Authors: Li-yan Xue, Nan Hu, Yong-mei Song, Shuang-mei Zou, Jian-zhong Shou, Lu-xia Qian, Li-qun Ren, Dong-mei Lin, Tong Tong, Zu-gen He, Qi-min Zhan, Philip R Taylor and Ning Lu
    Citation: BMC Cancer 2006 6:296
  4. The development of targeted therapies has created a pressing clinical need for the rapid and robust molecular characterisation of cancers. We describe here the application of high-resolution melting analysis (...

    Authors: Michael Krypuy, Genni M Newnham, David M Thomas, Matthew Conron and Alexander Dobrovic
    Citation: BMC Cancer 2006 6:295
  5. Drug resistance to chemotherapy is often associated with increased malignancy in neuroblastoma (NB). One explanation for the link between resistance and malignancy might be that resistance facilitates cancer p...

    Authors: Roman A Blaheta, Frederick H Daher, Martin Michaelis, Christoph Hasenberg, Eva M Weich, Dietger Jonas, Rouslan Kotchetkov, Hans Willhelm Doerr and Jindrich Cinatl jr
    Citation: BMC Cancer 2006 6:294
  6. A large number of renal cancer patients shows poor or partial response to chemotherapy and the mechanisms have not been still understood. Multi-drug resistance is the principal mechanism by which many cancers ...

    Authors: Chiara Mignogna, Stefania Staibano, Vincenzo Altieri, Gaetano De Rosa, Giuseppe Pannone, Angela Santoro, Rosanna Zamparese, Massimino D'Armiento, Romualdo Rocchetti, Ernesto Mezza, Mario Nasti, Viviana Strazzullo, Vittorino Montanaro, Massimo Mascolo and Pantaleo Bufo
    Citation: BMC Cancer 2006 6:293
  7. Wee1 kinase plays a critical role in maintaining G2 arrest through its inhibitory phosphorylation of cdc2. In previous reports, a pyridopyrimidine molecule PD0166285 was identified to inhibit Wee1 activity at ...

    Authors: Osamu Hashimoto, Masako Shinkawa, Takuji Torimura, Toru Nakamura, Karuppaiyah Selvendiran, Masaharu Sakamoto, Hironori Koga, Takato Ueno and Michio Sata
    Citation: BMC Cancer 2006 6:292
  8. Breast cancer in women is increasingly frequent, and care is complex, onerous and expensive, all of which lend urgency to improvements in care. Quality measurement is essential to monitor effectiveness and to ...

    Authors: Howard M Schachter, Vasil Mamaladze, Gabriela Lewin, Ian D Graham, Melissa Brouwers, Margaret Sampson, Andra Morrison, Li Zhang, Peter O'Blenis and Chantelle Garritty
    Citation: BMC Cancer 2006 6:291
  9. Prognosis of esophageal cancer is poor despite curative surgery. The chemokine receptor CXCR4 has been proposed to distinctly contribute to tumor growth, dissemination and local immune escape in a limited numb...

    Authors: Ines Gockel, Carl C Schimanski, Christian Heinrich, T Wehler, K Frerichs, Daniel Drescher, Christian von Langsdorff, Mario Domeyer, Stefan Biesterfeld, Peter R Galle, Theodor Junginger and Markus Moehler
    Citation: BMC Cancer 2006 6:290
  10. To date, there is no standard treatment for unresectable malignant peritoneal mesothelioma; either best supportive care or systemic chemotherapy with palliative intent are accepted options.

    Authors: Gianpiero Fasola, Fabio Puglisi, Alessandro Follador, Marianna Aita, Silvia Di Terlizzi and Ornella Belvedere
    Citation: BMC Cancer 2006 6:289
  11. Basic research of gefitinib (Iressa, ZD1839) has demonstrated the combination effects of gefitinib and chemotherapy were sequence-dependent. To evaluate the efficacy of sequential administration of gefitinib f...

    Authors: Jian Ming Xu, Yu Han, Yue Min Li, Chuan Hua Zhao, Yan Wang and Angelo Paradiso
    Citation: BMC Cancer 2006 6:288
  12. Continuous exposure to various environmental carcinogens and genetic polymorphisms of xenobiotic-metabolizing enzymes (XME) are associated with many types of human cancers, including esophageal squamous cell c...

    Authors: Zemin Wang, Lili Tang, Guiju Sun, Yuntian Tang, Yin Xie, Shaokang Wang, Xu Hu, Weimin Gao, Stephen B Cox and Jia-Sheng Wang
    Citation: BMC Cancer 2006 6:287
  13. Chronic injury deregulates cellular homeostasis and induces a number of alterations leading to disruption of cellular processes such as cell cycle checkpoints and apoptosis, driving to carcinogenesis. The stre...

    Authors: Cynthia C Castronuovo, Paula A Sacca, Roberto Meiss, Fabiana A Caballero, Alcira Batlle and Elba S Vazquez
    Citation: BMC Cancer 2006 6:286
  14. Anti-angiogenic treatment is believed to have at least cystostatic effects in highly vascularized tumours like pancreatic cancer. In this study, the treatment effects of the angiogenesis inhibitor Cilengitide ...

    Authors: Helmut Friess, Jan M Langrehr, Helmut Oettle, Jochen Raedle, Marco Niedergethmann, Christian Dittrich, Dieter K Hossfeld, Herbert Stöger, Bart Neyns, Peter Herzog, Pascal Piedbois, Frank Dobrowolski, Werner Scheithauer, Robert Hawkins, Frieder Katz, Peter Balcke…
    Citation: BMC Cancer 2006 6:285
  15. The aim of this paper is to analyze changes in thyroid cancer incidence trends in Lithuania during the period 1978–2003 using joinpoint regression models, with special attention to the period 1993–2003.

    Authors: Giedre Smailyte, Edita Miseikyte-Kaubriene and Juozas Kurtinaitis
    Citation: BMC Cancer 2006 6:284
  16. Nasopharyngeal carcinomas (NPC) are consistently associated with the Epstein-Barr virus (EBV). Their malignant epithelial cells contain the viral genome and express several antigenic viral proteins. However, t...

    Authors: Cécile Keryer-Bibens, Catherine Pioche-Durieu, Cécile Villemant, Sylvie Souquère, Nozomu Nishi, Mitsuomi Hirashima, Jaap Middeldorp and Pierre Busson
    Citation: BMC Cancer 2006 6:283
  17. Recently it has been reported that, toll-like receptors (TLRs) are expressed on a series of tumor cells, such as colon cancer, breast cancer, prostate cancer, melanoma and lung cancer. Although some cancer cel...

    Authors: Ferdaus Hassan, Shamima Islam, Gantsetseg Tumurkhuu, Yoshikazu Naiki, Naoki Koide, Isamu Mori, Tomoaki Yoshida and Takashi Yokochi
    Citation: BMC Cancer 2006 6:281
  18. A functional vascular network is essential for the survival, growth and spread of solid tumours, making blood vessels a key target for therapeutic strategies. Combretastatin A-4 phosphate (CA-4-P) is a tubulin...

    Authors: Gabi U Dachs, Andrew J Steele, Claudia Coralli, Chryso Kanthou, Andrew C Brooks, Sarah P Gunningham, Margaret J Currie, Ally I Watson, Bridget A Robinson and Gillian M Tozer
    Citation: BMC Cancer 2006 6:280
  19. The advantage of hyperfractionated accelerated radiation therapy for advanced head and neck cancer has been reported. Furthermore, randomized trials and meta-analyses have confirmed the survival benefit of add...

    Authors: Peter Stadler, Kurt Putnik, Thore Kreimeyer, Lisa D Sprague, Oliver Koelbl and Christof Schäfer
    Citation: BMC Cancer 2006 6:279
  20. Several studies showed that gain-of-function somatic mutations affecting the catalytic domain of EGFR in non-small cell lung carcinomas were associated with response to gefitinib and erlotinib, both EGFR-tyrosine...

    Authors: Tanios Bekaii-Saab, Nita Williams, Christoph Plass, Miguel Villalona Calero and Charis Eng
    Citation: BMC Cancer 2006 6:278
  21. Phase III trials evaluating the efficacy of gefitinib (IRESSA) in non-small cell lung cancer (NSCLC) lend support to the need for improved patient selection in terms of gefitinib use. Mutation of the epidermal...

    Authors: Rintaro Noro, Akihiko Gemma, Seiji Kosaihira, Yutaka Kokubo, Mingwei Chen, Masahiro Seike, Kiyoko Kataoka, Kuniko Matsuda, Tetsuya Okano, Yuji Minegishi, Akinobu Yoshimura and Shoji Kudoh
    Citation: BMC Cancer 2006 6:277
  22. Breast cancer subtypes identified in genomic studies have different underlying genetic defects. Mutations in the tumor suppressor p53 occur more frequently in estrogen receptor (ER) negative, basal-like and HE...

    Authors: Melissa A Troester, Jason I Herschkowitz, Daniel S Oh, Xiaping He, Katherine A Hoadley, Claire S Barbier and Charles M Perou
    Citation: BMC Cancer 2006 6:276
  23. Human breast cancer is a heterogeneous disease, histopathologically, molecularly and phenotypically. The molecular basis of this heterogeneity is not well understood. We have used a mouse model of DCIS that co...

    Authors: Ruria Namba, Jeannie E Maglione, Ryan R Davis, Colin A Baron, Stephenie Liu, Condie E Carmack, Lawrence JT Young, Alexander D Borowsky, Robert D Cardiff and Jeffrey P Gregg
    Citation: BMC Cancer 2006 6:275
  24. Health related quality of life (HRQOL) is an important outcome after treatment for upper gastrointestinal carcinoma. This study aimed to compare HRQOL in patients with advanced gastric cancer (GC) receiving ei...

    Authors: Sanambar Sadighi, Mohammad Ali Mohagheghi, Ali Montazeri and Zahra Sadighi
    Citation: BMC Cancer 2006 6:274
  25. Currently 1 in 11 women over the age of 60 in Australia are diagnosed with breast cancer. Following treatment, most breast cancer patients are left with shoulder and arm impairments which can impact significan...

    Authors: Sharon L Kilbreath, Kathryn M Refshauge, Jane M Beith, Leigh C Ward, Judy M Simpson and Ross D Hansen
    Citation: BMC Cancer 2006 6:273
  26. Androgen-independent prostate adenocarcinomas are responsible for about 6% of overall cancer deaths in men.

    Authors: Elizabeth Devilard, Franck Bladou, Olivier Ramuz, Gilles Karsenty, Jean-Philippe Dalès, Gwenaëlle Gravis, Catherine Nguyen, François Bertucci, Luc Xerri and Daniel Birnbaum
    Citation: BMC Cancer 2006 6:272
  27. Breast cancer is the commonest cancer among women in Nigeria and globally. In Nigeria, late presentations of breast cancer cases have also been consistent for three decades. In an environment where there is no...

    Authors: O Abimbola Oluwatosin and Oladimeji Oladepo
    Citation: BMC Cancer 2006 6:271
  28. Matrix metalloproteinases (MMP) have been shown to play a role in colorectal cancer (CRC). More recently, MMP1, MMP3 and MMP7 functional gene promoter polymorphisms have been found to be associated with CRC occur...

    Authors: Astrid Lièvre, Jacqueline Milet, Jérôme Carayol, Delphine Le Corre, Chantal Milan, Alexandre Pariente, Bernard Nalet, Jacques Lafon, Jean Faivre, Claire Bonithon-Kopp, Sylviane Olschwang, Catherine Bonaiti-Pellié and Pierre Laurent-Puig
    Citation: BMC Cancer 2006 6:270
  29. In breast cancer current guidelines do not recommend the routine use of serum tumour markers. Differently, we observed that CEA-TPA-CA15.3 (carcinoembryonic (CEA) tissue polypeptide (TPA) and cancer associated...

    Authors: Andrea Nicolini, Gianna Tartarelli, Angelo Carpi, Maria Rita Metelli, Paola Ferrari, Loretta Anselmi, Massimo Conte, Piero Berti and Paolo Miccoli
    Citation: BMC Cancer 2006 6:269
  30. The transcription factor 7-like 2 (TCF7L2) is a critical component of the Wnt/β-catenin pathway. Aberrant TCF7L2 expression modifies Wnt signaling and mediates oncogenic effects through the upregulation of c-MYC ...

    Authors: Barbara Burwinkel, Kalai S Shanmugam, Kari Hemminki, Alfons Meindl, Rita K Schmutzler, Christian Sutter, Barbara Wappenschmidt, Marion Kiechle, Claus R Bartram and Bernd Frank
    Citation: BMC Cancer 2006 6:268
  31. In search of a suitable GSH-depleting agent, a novel copper complex viz., copper N-(2-hydroxyacetophenone) glycinate (CuNG) has been synthesized, which was initially found to be a potential resistance modifying a...

    Authors: Ananda Mookerjee, Jayati Mookerjee Basu, Surajit Majumder, Shilpak Chatterjee, Gouri S Panda, Pranabananda Dutta, Smarajit Pal, Pratima Mukherjee, Thomas Efferth, Syamal Roy and Soumitra K Choudhuri
    Citation: BMC Cancer 2006 6:267
  32. Detection of circulating malignant cells (CMCs) through a reverse transcriptase-polymerase chain reaction (RT-PCR) assay seems to be a demonstration of systemic disease. We here evaluated the prognostic role o...

    Authors: Giuseppe Palmieri, Sabrina MR Satriano, Mario Budroni, Antonio Cossu, Francesco Tanda, Sergio Canzanella, Corrado Caracò, Ester Simeone, Antonio Daponte, Nicola Mozzillo, Giuseppe Comella, Giuseppe Castello and Paolo A Ascierto
    Citation: BMC Cancer 2006 6:266
  33. Epstein-Barr virus (EBV) is the causative agent of immunosuppression associated lymphoproliferations such as post-transplant lymphoproliferative disorder (PTLD), AIDS related immunoblastic lymphomas (ARL) and ...

    Authors: Laszlo Markasz, György Stuber, Emilie Flaberg, Åsa Gustafsson Jernberg, Staffan Eksborg, Eva Olah, Henriette Skribek and Laszlo Szekely
    Citation: BMC Cancer 2006 6:265
  34. There is a paucity of literature on the referral outcome of patients seen in phase I trial clinics in academic oncology centres. This study aims to provide information on the accrual rate and to identify obsta...

    Authors: Jeremy Ho, Gregory R Pond, Colin Newman, Martha Maclean, Eric X Chen, Amit M Oza and Lillian L Siu
    Citation: BMC Cancer 2006 6:263
  35. The reciprocal (9;22) translocation fuses the bcr (breakpoint cluster region) gene on chromosome 22 to the abl (Abelson-leukemia-virus) gene on chromosome 9. Depending on the breakpoint on chromosome 22 (the Phil...

    Authors: Xiaomin Zheng, Saskia Güller, Tim Beissert, Elena Puccetti and Martin Ruthardt
    Citation: BMC Cancer 2006 6:262
  36. From 1968 to 2002, Singapore experienced an almost three-fold increase in breast cancer incidence. This increase appeared to be different across the three main ethnic groups: Chinese, Malays and Indians. This ...

    Authors: Xueling Sim, R Ayesha Ali, Sara Wedren, Denise Li-Meng Goh, Chuen-Seng Tan, Marie Reilly, Per Hall and Kee-Seng Chia
    Citation: BMC Cancer 2006 6:261
  37. Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies and appears to arise mainly from transformation of pre-existing differentiated thyroid cancer (DTC). However, the carcinogenic m...

    Authors: Junko Akaishi, Masamitsu Onda, Junichi Okamoto, Shizuyo Miyamoto, Mitsuji Nagahama, Kouichi Ito, Akira Yoshida and Kazuo Shimizu
    Citation: BMC Cancer 2006 6:260
  38. Circulating plasma Epstein Barr Virus DNA (EBV-DNA) is a sensitive and specific marker of nasopharyngeal carcinoma (NPC). The mainstay of treatment of metastatic NPC is systemic chemotherapy and resection for ...

    Authors: Stephen L Chan, Edwin P Hui, Sing F Leung, Anthony TC Chan and Brigette BY Ma
    Citation: BMC Cancer 2006 6:259
  39. Bowel cancer is common and is a major cause of death. Meta-analysis of randomised controlled trials estimates that screening for colorectal cancer using faecal occult blood (FOB) test reduces mortality from co...

    Authors: Sue Wilson, Michael JO Wakelam, Richard FD Hobbs, Angela V Ryan, Janet A Dunn, Val D Redman, Fiona Patrick, Lynne Colbourne, Ashley Martin and Tariq Ismail
    Citation: BMC Cancer 2006 6:258
  40. Two functional single nucleotide polymorphisms (SNPs) in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, C677T and A1298C, lead to decreased enzyme activity and affect chemosensitivity of tumor cells. ...

    Authors: Damali N Martin, Brenda J Boersma, Tiffany M Howe, Julie E Goodman, Leah E Mechanic, Stephen J Chanock and Stefan Ambs
    Citation: BMC Cancer 2006 6:257
  41. In a recent pilot report, we showed that Smac/DIABLO mRNA is expressed de novo in a subset of cervical cancer patients. We have now expanded this study and analyzed Smac/DIABLO expression in the primary lesions i...

    Authors: Abril Arellano-Llamas, Francisco J Garcia, Delia Perez, David Cantu, Magali Espinosa, Jaime G De la Garza, Vilma Maldonado and Jorge Melendez-Zajgla
    Citation: BMC Cancer 2006 6:256
  42. Maspin, a member of the serpin family, is a suppressor of tumor growth, an inhibitor of angiogenesis and an inducer of apoptosis. Maspin induces apoptosis by increasing Bax, a member of the Bcl-2 family of apo...

    Authors: Antonello A Romani, Paolo Soliani, Silvia Desenzani, Angelo F Borghetti and Pellegrino Crafa
    Citation: BMC Cancer 2006 6:255
  43. Epigenetic alterations and loss of heterozygosity are mechanisms of tumor suppressor gene inactivation. A new carcinogenic pathway, targeting the RAS effectors has recently been documented. RASSF1A, on 3p21.3,...

    Authors: Paula Lázcoz, Jorge Muñoz, Manuel Nistal, Ángel Pestaña, Ignacio Encío and Javier S Castresana
    Citation: BMC Cancer 2006 6:254
  44. HNSCC progression to adjacent tissue and nodes may be mediated by altered glycoproteins and glycolipids such as MUC1 mucin. This report constitutes a detailed statistical study about MUC1 expression and anti-M...

    Authors: Martín E Rabassa, María V Croce, Adrián Pereyra and Amada Segal-Eiras
    Citation: BMC Cancer 2006 6:253
  45. SnoN is an important regulator of the transforming growth factor beta (TGFβ) signalling pathway and has been shown to exhibit both tumour promotion and suppression activity.

    Authors: June A Chia, Lisa A Simms, Sarah-Jane Cozzi, Joanne Young, Jeremy R Jass, Michael D Walsh, Kevin J Spring, Barbara A Leggett and Vicki LJ Whitehall
    Citation: BMC Cancer 2006 6:252
  46. Bowel cancer is common and is a major cause of death. Most people with bowel symptoms who meet the criteria for urgent referral to secondary care will not be found to have bowel cancer, and some people who are...

    Authors: Angela V Ryan, Sue Wilson, Michael JO Wakelam, Sally A Warmington, Janet A Dunn, Richard FD Hobbs, Ashley Martin and Tariq Ismail
    Citation: BMC Cancer 2006 6:251
  47. The efficacy of screening for colorectal cancer using a simple blood-based assay for the detection of tumor cells disseminated in the circulation at an early stage of the disease is gaining positive feedback f...

    Authors: Rossella Solmi, Giampaolo Ugolini, Giancarlo Rosati, Simone Zanotti, Mattia Lauriola, Isacco Montroni, Marco del Governatore, Antonello Caira, Mario Taffurelli, Donatella Santini, Domenico Coppola, Lia Guidotti, Paolo Carinci and Pierluigi Strippoli
    Citation: BMC Cancer 2006 6:250
  48. It remains unknown whether primary ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is a homogeneous entity, as there are few reports of the results ...

    Authors: Kazuki Tanimoto, Naohiro Sekiguchi, Yukiko Yokota, Akihiro Kaneko, Takashi Watanabe, Akiko Miyagi Maeshima, Yoshihiro Matsuno, Mine Harada, Kensei Tobinai and Yukio Kobayashi
    Citation: BMC Cancer 2006 6:249

Featured videos

View featured videos from across the BMC-series journals